EC Number   |
Activating Compound |
Reference |
|---|
   3.4.11.9 | 4-chloromercuribenzoate |
slight activation at 0.1 mM |
754215 |
| 3.4.11.9 | 4-chloromercuriphenyl sulfonic acid |
inhibits hydrolysis of Gly-Pro-Hyp, activates hydrolysis of bradykinin |
36058 |
| 3.4.11.9 | aminoguanidine |
reactivates enzyme mutant R353 |
755161 |
| 3.4.11.9 | bacitracin |
slight activation at 0.1 mM |
754215 |
| 3.4.11.9 | bestatin |
slight activation at 0.1 mM |
754215 |
| 3.4.11.9 | glutathione |
activates the enzyme in presence of Mn2+ or Co2+, and slightly in presence of Zn2+ |
649941 |
| 3.4.11.9 | guanidine hydrochloride |
strongly reactivates enzyme mutant R353 at 0.1-10 mM, approximately 90% of the activity lost in theR535A hcAMPP mutant is regained in the presence of 30 mM guanidine hydrochloride. It has neither an observable rescue effect on wild-type hcAMPP nor on the Y527F mutant |
755161 |
| 3.4.11.9 | methylguanidine |
reactivates enzyme mutant R353 |
755161 |
| 3.4.11.9 | more |
activation of the enzyme is observed after processing at 100-200 MPa and 20-30°C |
753628 |
| 3.4.11.9 | more |
women on the oral contraceptive pill have higher age-adjusted plasma AP-P compared to women not on the oral contraceptive pill or males |
699834 |
